Contribution of <i>TARDBP</i> mutations to sporadic amyotrophic lateral sclerosis
Hussein Daoud(Université de Montréal), Guy A. Rouleau(Montreal Neurological Institute and Hospital), William Camu, Vincent Meininger(Sorbonne Université), Paul N. Valdmanis(Centre Hospitalier de l’Université de Montréal), Edor Kabashi(Inserm), Nicolas Dupré(Hôpital de l'Enfant-Jésus), Patrick A. Dion(Centre Hospitalier de l’Université de Montréal)
Cited by 191
Related Papers
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
|New England Journal of Medicine|1994|2.2k
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
|Nature Genetics|2008|1.5k
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
|The Lancet|1996|1.3k